Abstract:Abstract Background: Associations between lifestyle, hormonal and reproductive factors and survival for epithelial ovarian cancer (EOC) have been studied, however, reports lack stratification by racial and ethnic group. Through the Ovarian Cancer Association Consortium (OCAC), we analyzed associations between survival and EOC risk factors by racial and ethnic group across Asian, Hispanic, Native Hawaiian/Pacific Islander (NHPI) and Non-Hispanic White women with EOC to help inform associations with prognosis. Methods: Participants came from 15 eligible case-control studies from Australia, Canada, England, and the USA with hormonal factors (oral contraceptive use, postmenopausal hormone use, body mass index [BMI]), reproductive factors (age at menarche, parity, breastfeeding, tubal ligation, hysterectomy, endometriosis), smoking and family history. The 12,818 invasive EOC cases were reported as Asian and NHPI (n=908, including 98 NHPI); Hispanic (n=490); and White (n=11,420). Cox proportional hazards regression models estimated hazard ratios (HR) and 95% confidence intervals (95% CI) for risk of all-cause mortality with race and ethnicity as an exposure, and risk factors stratified by race and ethnicity. Models were stratified by study, 10-year age group and stage at diagnosis, and adjusted for age at diagnosis (continuous) and histology. The models with race and ethnicity as the exposure were additionally adjusted for BMI, smoking and postmenopausal hormone use. We assessed heterogeneity in the risk factor associations between racial and ethnic groups using the Wald test with an interaction term for race and ethnicity for each exposure. Results: The mean follow-up after a diagnosis of EOC was 6.1 years (standard deviation = 4.8), with 7512 deaths during the follow-up period (59% of EOC). Compared to White patients, NHPI women with EOC had an increased risk of mortality (HR=1.49, 95% CI=1.08-2.07). There was no statistically significant heterogeneity in associations between risk factors and EOC mortality across racial and ethnic groups. However, we observed differences by racial and ethnic groups for postmenopausal hormone therapy use with a pronounced inverse association for the combined Asian and NHPI group (HR=0.65, 95% CI 0.49-0.88), less so for White and Hispanic women (HR=0.90, 95% CI 0.84-0.95 and HR=0.81, 95% CI 0.57-1.14, respectively). High recent BMI (≥30 kg/m2 compared with <25) was associated with increased risk of mortality in Hispanic and White women only (HR=1.43, 95% CI 1.00-2.03 and HR=1.14, 95% CI 1.06-1.22, respectively). Current smoking was associated with higher mortality risk among White women (HR=1.15, 95% CI 1.07-1.25) but not in the other groups. Conclusions: We observed that compared with White women, NHPI women with EOC had a higher risk of mortality. The known association between postmenopausal hormone therapy use and reduced risk of mortality was particularly pronounced for the combined Asian and NHPI group. More work is needed to understand the disparity in mortality outcome for NHPI women with EOC. Citation Format: Nicola S. Meagher, Kami K. White, Lynne R. Wilkens, Penelope M. Webb, Anna H. Wu, Lauren C. Peres, Melissa A. Merritt. Associations between risk factors and epithelial ovarian cancer survival by racial and ethnic group: an analysis from the ovarian cancer association consortium [abstract]. In: Proceedings of the AACR Special Conference on Ovarian Cancer; 2023 Oct 5-7; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(5 Suppl_2):Abstract nr B113.

Abstract A018: Inflammatory and insulinemic dietary and lifestyle patterns and incidence of endometrial cancer: The Multiethnic Cohort

Abstract C119: Rising incidence and racial disparities of early-onset endometrial cancer in the United States, 1995-2018

Abstract C163: Interaction of germline genetic variation and environmental factors in endometrial cancer prevalence in a population biobank

The Dietary Inflammatory Index Is Associated with Colorectal Cancer Risk in the Multiethnic Cohort

Abstract 2203: Dietary patterns and prostate cancer risk in the Multiethnic Cohort Study

Abstract C165: Interrogating the Tumor and Immune Microenvironment of Endometrial Cancers Among a Diverse Cohort of Cases

Abstract 2218: Dietary insulinemic potential and survival after breast cancer diagnosis

Abstract B056: Inflammatory dietary pattern and risk of multiple myeloma in US Black women

Abstract A003: Decomposing racial and ethnic disparities in endometrial cancer survival

Abstract P215: Inflammatory and Insulinemic Dietary Patterns Are Associated With Modestly Increased Total and Cardiometabolic Mortality Among Low-Income Americans

The Association Between Metabolic Abnormality and Endometrial Cancer: a Large Case-Control Study in China.

Hyperinsulinemic and Pro-Inflammatory Dietary Patterns and Metabolomic Profiles Are Associated with Increased Risk of Total and Site-Specific Cancers among Postmenopausal Women

Dietary Inflammatory and Insulinemic Potentials, Plasma Metabolome and Risk of Colorectal Cancer

Abstract IA011: Understanding field carcinogenesis in obesity-related endometrial cancer

Association of Dietary Insulinemic and Inflammatory Potential with Risk of Liver Cancer and Chronic Liver Disease Mortality in Postmenopausal Women: a Prospective Cohort Study.

Abstract B113: Associations between risk factors and epithelial ovarian cancer survival by racial and ethnic group: an analysis from the ovarian cancer association consortium

Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes

Hypertension and risk of endometrial cancer: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2)

Pilot Data Suggest That Obesity and Presence of Malignancy Are Associated with Altered Immune Cell Infiltration in Endometrial Biopsies

Unraveling the causal association between lifestyle and metabolic factors with endometrial cancer: evidence from a Mendelian randomization study

Abstract C115: Chromatin acetylation at H3K9ac, inflammatory signaling, and evidence for immune cell senescence in Los Angeles women with insulin-resistance